BSC Buys Target; Sulzer Medica Spins Off
Executive Summary
For the last couple of years, one of the most closely-watched battles in the medical device industry was that between Target Therapeutics Inc., with 1996 sales of $47.5mm, and its much larger competitors, Boston Scientific Corp. and Johnson & Johnson in the struggle for the market for miniature catheters used in minimally-invasive applications, particularly interventional neurology.
You may also be interested in...
Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Cosmetic And Personal Care Trademark Review 19 January, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.
Need a specific report? 1000+ reports available
Buy Reports